NEW YORK (360Dx) – Thermo Fisher Scientific received 510(k) clearance from the US Food and Drug Administration last month for its assay for assessing patients suspected of having sepsis, one of a number of diagnostic tests that the agency cleared for marketing in June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.